About DAXOR
Executive Team
Corporate Governance
Medical Advisory Board
Board of Directors
Investors
Daxor Corporation
Privacy Statement
SEC Filings
Press Releases
Contact Us
Navigation
Daxor
The Blood Volume Company
Search for:
The BVA-100
Why The BVA-100 ?
Product Literature
Ideal Blood Calculator
Site Requirements
How It Works
For Patients
Why is Blood Volume Important?
BVA FAQ’s
Healthcare Professionals
Blood Volume Measurement
Clinical Evidence
Case Studies
CRITICAL CARE
HEART FAILURE
Indications
The only direct, swift and accurate way to measure total blood volume and red blood cell volume in the clinical setting
Read More
Actionable results with 98% accuracy
Quantifies the excess or deficit vs patient-specific ideal
Non-invasive, single-venipuncture technique
BVA-100Blood Volume Analyzer
Key Features    
Actionable results with 98% accuracy
Quantifies the excess or deficit vs patient-specific ideal
Non-invasive, single-venipuncture technique
Latest News
Two New Studies from the Mayo Clinic and Lankenau Medical Center Presented at Heart Failure Society of America 2016 Highlight Unique Ability of BVA to Identify High Risk at Discharge in Hospitalized Heart Failure Patients
New York, NY September 29, 2016 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces two new studies presented at the Heart Failure Society of America meeting this month highlighting risks for hospitalized heart failure patients detectable by direct blood volume measurement (Daxor BVA-100). Michael Feldschuh, President and […]
Read More
Daxor Corporation Announces Hiring of Chief Financial Officer
New York, NY June 17, 2016 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces the hiring of Eric P. Coleman as its new Chief Financial Officer effective June 6, 2016, reporting directly to Michael Feldschuh, Acting President & CEO of Daxor Corporation. “Mr. Coleman will be responsible […]
Read More
Featured
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.
Follow Us on TwitterMy Tweets
Contact Information350 Fifth Avenue, Suite 4740
New York, NY 10118
Phone: 212-330-8500
FDA ClearedThe BVA-100 is an FDA-cleared diagnostic instrument to measure a patient’s blood volume, calculate an ideal blood volume that the patient should have, and
indicate hypovolemia or hypervolemia with statistics showing the quality of results.
Contact Us
Press Releases